Pulmonary Verruconis Infection in an Immunocompetent Patient: A Case Report and Literature Review
Journal of Fungi · 29.08.2025 · 11 (9) · 634
DOI: 10.3390/jof11090634 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Fungi, online erschienen am 29.08.2025. Verfasst von Lulu Xu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37228, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Senior Medical Talents Program of Chongqing for Young and Middle-aged, Young and Middle-aged Senior Medical Talents Studio, Chongqing Clinical Research Centre for Geriatric Diseases Project.
Abstract (Originalsprache)
Verruconis species are thermophilic, darkly pigmented fungi commonly found in hot environments. Despite their environmental ubiquity, fewer than fifty human infections have been reported, with V. gallopava responsible for most cases. While infections primarily occur in immunocompromised individuals, only six cases in immunocompetent patients have been documented. We describe a case of pulmonary Verruconis infection in a 75-year-old immunocompetent woman. Despite broad-spectrum antifungal treatments, including liposomal amphotericin B and voriconazole, the patient’s condition deteriorated. Bronchoalveolar lavage (BAL) revealed hyphal forms, and fungal culture identified a Verruconis species. Antifungal susceptibility tests showed low minimal inhibitory concentrations (MICs) for amphotericin B (1 μg/mL) and voriconazole (0.5 μg/mL). Clinical manifestations of Verruconis infection in immunocompetent pneumonia patients are non-specific. Structural lung disease was identified as the primary risk factor in such hosts. BAL fungal cultures and metagenomics are valuable tools in diagnosing rare fungal infections. Treatment regimens vary, with amphotericin B and triazoles being the most commonly used antifungal agents. Currently, there are no standardized guidelines for diagnosis or treatment. Further studies are needed to establish clinical protocols.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37228, USA.
- Chongqing Clinical Research Center for Geriatric Diseases, Department of Geriatrics, Chongqing General Hospital, Chongqing University, Chongqing 401147, China.
Förderung
- Senior Medical Talents Program of Chongqing for Young and Middle-aged
- Young and Middle-aged Senior Medical Talents Studio
- Chongqing Clinical Research Centre for Geriatric Diseases Project
- Chongqing Talent Contract System Project
Zitieren
APA
Xu, L., & Tao, L. (2025). Pulmonary Verruconis Infection in an Immunocompetent Patient: A Case Report and Literature Review. Journal of Fungi, 11(9), 634. https://doi.org/10.3390/jof11090634
Vancouver
Xu L, Tao L. Pulmonary Verruconis Infection in an Immunocompetent Patient: A Case Report and Literature Review. Journal of Fungi. 2025;11(9):634. doi:10.3390/jof11090634
BibTeX
@article{Xu2025,
author = {Xu, Lulu and Tao, Lili},
title = {Pulmonary Verruconis Infection in an Immunocompetent Patient: A Case Report and Literature Review},
journal = {Journal of Fungi},
year = {2025},
volume = {11},
number = {9},
pages = {634},
doi = {10.3390/jof11090634}
}
EUVIMED